Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996: A detailed analysis of 108 cases

Archives of Internal Medicine

Volumn 157, Issue 17, 1997, Pages 1965-1971

  Watanakunakorn, Chatrchai ^a,b   Bailey, Thomas A ^b  

^a ST ELIZABETH HEALTH CENTER   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COUGHING; DIAGNOSTIC VALUE; DYSPNEA; FEMALE; FEVER; GRAM STAINING; HUMAN; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL;

EID: 0030883574     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.17.1965     Document Type: Article

References (64)

1. Barrett-Connor E. The non-value of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis. 1971;103:845-848.
2. Drew WL. Value of sputum culture in diagnosis of pneumococcal pneumonia. J Clin Microbiol. 1977;6:62-65.
3. Rein MF, Gwaltney JM Jr, O'Brien WM, Jennings RH, Mandell GL. Accuracy of Gram stain in identifying pneumococci in sputum. JAMA. 1978;239:2671-2673.
4. Perlino CH. Laboratory diagnosis of pneumonia due to Streptococcus pneumoniae. J Infect Dis. 1984;150:139-144.
5. Palmer DL. Laboratory diagnosis of Streptococcus pneumoniae. J Infect Dis. 1985; 151:378.
6. Musher DM. Gram stain and culture of sputum to diagnose bacterial pneumonia. J Infect Dis. 1985;152:1096.
7. Marrie TJ. Community-acquired pneumonia. Clin Infect Dis. 1994;18:501-515.
8. Chalasani NP, Valdecanas AL, Gopal AK, McGowan JE Jr, Jurado RL. Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks. Chest. 1995;108:932-936.
9. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992;15:77-83.
10. Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP, the Pneumococcus Study Group. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis. 1993; 168:1532-1536.
11. Parkinson AJ, Davidson M, Fitzgerald MA, Bulkow LR, Parks DJ. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska 1986-1990. J infect Dis. 1994;170:461-464.
12. Mason EO, Lamberth L, Lichenstein R, Kaplan SL. Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in vitro susceptibility to selected oral antibiotics. J Antimicrob Chemother. 1995;36:1043-1048.
13. Stanek RJ, Mufson MA. Emergence of penicillin-resistant invasive pneumococci in a single American community. Am J Med Sci. 1995;310:150-155.
14. Fairchok MP, Ashton WS, Fischer GW. Carriage of penicillin-resistant pneumococci in a military population in Washington, DC: risk factors and correlation with clinical isolates. Clin Infect Dis. 1996;22:966-972.
15. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996;40:1208-1213.
16. Knaus WA, Draper WA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
17. Centers for Disease Control. Updates on adult immunization: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep. 1991;40(RR-12):42-44.
18. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Villanove, Pa: National Committee for Clinical Laboratory Standards; 1985. NCCLS publication M7-A.
19. Skulnick M, Small GW, Lo P. Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicilin, cefotaxime, and ceftriaxone. J Clin Microbiol. 1995;33:2334-2337.
20. Tilghman RC, Finland M. Clinical significance of bacteremia in pneumococcic pneumonia. Arch Intern Med. 1937;59:602-619.
21. Casadevall A, Scharff MD. Serum therapy revisited: animal models of infection and development of passive antibody therapy. Antimicrob Agents Chemother. 1994;38:1695-1702.
22. Thompson RT, Ruegsegger JM, Blankenhorn MA, Hamburger M. Primary pneumococcic pneumonia at the Cincinnati General Hospital, 1936-1950. J Lab Clin Med. 1951;37:73-87.
23. Hamburger M, Berman JR, Thompson RT, Blankenhorn MA. The treatment of pneumococcal pneumonia by penicillin in aqueous solution at long intervals: effectiveness of two doses in first twenty-four hours followed by single daily infections. J Lab Clin Med. 1949;34:59-66.
24. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 1964;60:759-776.
25. Mufson MA, Kruss DM, Wasil RE, Metzger WI. Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Intern Med. 1974; 134:505-510.
26. Fedson DS, Chiarello LA. Previous hospital care and pneumococcal bacteremia: importance for pneumococcal immunization. Arch Intern Med. 1983;143:885-889.
27. Gransden WR, Eykyn SJ, Phillips I. Pneumococcal bacteremia: 325 episodes diagnosed at St Thomas's Hospital. BMJ. 1985;290:505-508.
28. Finkelstein MS, Petkun WM, Freedman ML, Antopol SC. Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome. J Am Geriatr Soc. 1983;31:19-27.
29. Filice GA, Darby CP, Fraser DW. Pneumococcal bacteremia in Charleston County, South Carolina. Am J Epidemiol. 1980;112:828-835.
30. Hook EW III, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA. 1983;249:1055-1057.
31. Murphy TF, Fine BC. Bacteremic pneumococcal pneumonia in the elderly. Am J Med Sci. 1984;288:114-118.
32. Gruer LD, McKendrick MW, Geddes AM. Pneumococcal bacteremia: a continuing challenge. QJM. 1984;210:259-270.
33. Bruyn GAW, Van der Meer JWM, Hermans J, Knoppert W. Pneumococcal bacteremia in adults over a 10-year period at a university hospital, Leiden. Rev Infect Dis. 1988;10:446-450.
34. Knikka A, Syrjanen J, Renkonen O-V, Valtonen VV. Pneumococcal bacteremia during a recent decade. J Infect. 1992;24:157-168.
35. Mylotte JM, Beam TR Jr. Comparison of community-acquired and nosocomial pneumococcal pneumonia. Am Rev Respir Dis. 1981;123:265-268.
36. Ortquist A, Grepe A, Julander I, Kalin M. Bacteremic pneumococcal pneumonia in Sweden: clinical course and outcome and comparison with non-bacteremic pneumococcal and mycoplasma pneumonias. Scand J Infect Dis. 1988;20:163-171.
37. Kramer MR, Rudensky B, Hadas-Halperin I, Isacsohn M, Melzer E. Pneumococcal bacteremia: no change in mortality in 30 years: analysis of 104 cases and review of the literature. Isr J Med Sci. 1987;23:174-180.
38. Ortquist A, Kalin M, Julander I, Mufson M. Deaths in bacteremic pneumococcal pneumonia: a comparison of two populations: Huntington, W VA, and Stockholm, Sweden. Chest. 1993;103:710-716.
39. Esposito AL. Community-acquired bacteremic pneumococcal pneumonia: effect of age on manifestations and outcome. Arch Intern Med. 1984;144:945-948.
40. Watanakunakorn C, Greifenstein A, Stroh K, et al. Pneumococcal bacteremia in three community teaching hospitals from 1980-1989. Chest. 1993;103:1152-1156.
41. Banks RA, George RC, McNicol MW. Pneumococcal pneumonia with bacteraemia. Br J Dis Chest. 1984;78:352-357.
42. Pallares R, Gudiol F, Linares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med. 1987;317:18-22.
43. Marrie TJ. Bacteraemic pneumococcal pneumonia: a continously evolving disease. J Infect. 1992;24:247-255.
44. Mirzanejad Y, Roman S, Talbot J, Nicolle L, the Pneumococcal Bacteremia Study Group. Pneumococcal bacteremia in tertiary care hospitals in Winnipeg, Canada. Chest. 1996;109:173-178.
45. Ortquist A, Kalin M. Bacteremic pneumococcal pneumonia in Stockholm, Sweden, in 1984. Scand J Infect Dis. 1988;20:451-452.
46. Laaveri T, Nikoskelainen J, Meurman O, Eerola E, Kotilainen P. Bacteremic pneumococcal disease in a teaching hospital in Finland. Scand J Infect Dis. 1996;28: 41-46.
47. Marfin AA, Sporrer J, Moore PS, Siefkin AD. Risk factors for adverse outcome in persons with pneumococcal pneumonia. Chest. 1995;107:457-462.
48. Janoff EN, O'Brien J, Thompson P, et al. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis. 1993;167:49-56.
49. Pesola GR, Charles A. Pneumococcal bacteremia with pneumonia: mortality in acquired immunodeficiency syndrome. Chest. 1992;101:150-155.
50. Gomez J, Banos V, Ruiz Gomez J, et al. Clinical significance of pneumococcal bacteraemias in a general hospital: a prospective study 1989-1993. J Antimicrob Chemother. 1995;36:1021-1030.
51. Plouffe JF, Breiman RF, Facklam RR, Franklin County Pneumonia Study Group. Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention. JAMA. 1996;275:194-198.
52. Lippmann ML, Goldberg SK, Walkenstein MD, Herring W, Gordon M. Bacteremic pneumococcal pneumonia: a community hospital experience. Chest. 1995; 108:1608-1613.
53. Duma RJ. Pneumococcal pneumonia. In: Bennett JC, Plum F, eds. Cecil Textbook of Medicine. Philadelphia, Pa: WB Saunders Co; 1996:1569-1576.
54. Perlino CA, Rimland D. Alcoholism, leukopenia, and pneumococcal sepsis. Am Rev Respir Dis. 1985;132:757-760.
55. Taryle DA, Potts DE, Sahn SA. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. Chest. 1978;74:170-173.
56. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev. 1990; 3:171-196.
57. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother. 1990;34:2075-2080.
58. Spika JS, Facklam RR, Plikaytis BD, Oxtoly MJ, the Pneumococcal Surveillance Working Group. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis. 1991;163:1273-1278.
59. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325:1453-1460.
60. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA. 1993;270:1826-1831.
61. Farr BM, Johnston L, Cobb DK, et al. Preventing pneumococcal bacteremia in patients at risk: results of a matched case-control study. Arch Intern Med. 1995; 155:2336-2340.
62. McBean AM, Babish JD, Prihoda R. The utilization of pneumococcal polysaccharide vaccine among elderly medicare beneficiaries, 1985 through 1988. Arch Intern Med. 1991;151:2009-2016.
63. Campbell JF, Donahue MA, Mochizuki RB, Nevin-Woods CL, Spika JS. Pneumococcal bacteremia in Hawaii: initial findings of a pneumococcal disease prevention project. Hawaii Med J. 1989;48:513-514, 517-518.
64. American College of Physicians. Guide for Adult Immunization. 3rd ed. Philadelphia, Pa: American College of Physicians; 1994.